Safety and preliminary clinical activity of repotrectinib in patients with advanced ROS1/TRK fusion-positive solid tumors (TRIDENT-1 study) Meeting Abstract
| Authors: | Drilon, A.; Cho, B. C.; Kim, D. W.; Lee, J.; Lin, J. J.; Zhu, V.; Camidge, R. D.; Stopatschinskaja, S.; Cui, J. J.; Hyman, D. M.; Ou, S. H.; Shaw, A. T.; Doebele, R. C. |
| Abstract Title: | Safety and preliminary clinical activity of repotrectinib in patients with advanced ROS1/TRK fusion-positive solid tumors (TRIDENT-1 study) |
| Meeting Title: | 44th ESMO Congress (ESMO 2019) |
| Journal Title: | Annals of Oncology |
| Volume: | 30 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2019 Sep 27-Oct 1 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-10-01 |
| Start Page: | mdz244.006 |
| Language: | English |
| ACCESSION: | WOS:000491295501261 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdz244.006 |
| Notes: | Meeting Abstract: 444PD -- Appears on page v162 of the abstract book -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work